F2 Bioscience I 2017 Ltd
- SEC CIK
- 0001838573
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.10% Owneras of Jun 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists F2 Bioscience I 2017 Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 (view filing)6:47 PM ET | Jun 21-23 | 2 days | Jovan-Embiricos Morana and 1 other10% Owner | SSale | −101.9K | $12.80 | −$1.30M | −15.9%537.4K after | 3 lots |